商务部、江苏省：支持江苏自贸试验区符合条件的医疗机构建设国家临床医学研究中心

Core Viewpoint - The article discusses the implementation of the "Biopharmaceutical Full Industry Chain Open Innovation Development Plan" in Jiangsu Free Trade Zone, emphasizing the enhancement of clinical research capabilities [1] Group 1: Clinical Research Enhancement - The plan supports the establishment of National Clinical Medical Research Centers in eligible medical institutions within Jiangsu Free Trade Zone [1] - It encourages public medical institutions to increase clinical research resources and conduct multi-center, large-sample clinical studies [1] - The initiative explores decentralized clinical trial pilots and participation in the formulation of international standards and common norms for clinical research [1] Group 2: Innovative Research Support - Medical institutions are encouraged to conduct clinical research in areas such as immunotherapy, stem cell therapy, and gene therapy, following regulations [1] - The plan supports investigator-initiated clinical research and the conduct of real-world studies [1] - A pilot program will establish regional biomedical research ethics review committees to promote mutual recognition of ethical review results among medical institutions [1]